在耐火性高胆固醇血清症患者的inclisiran诱导的固定药物喷发中
1Geriatric Medicine, Midland Metropolitan University Hospital, Birmingham, GBR.
Cureus
|January 9, 2026
概括
一名患者经历了一种罕见的固定药物喷发,来自inclisiran,一种新的降胆固醇疗法. 这凸显了监测皮肤对新型降脂药物的反应的必要性.
科学领域:
- 心脏病学 心脏病学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐火性高胆固醇血症需要先进的降脂疗法.
- 针对PCSK9的小干扰RNA (siRNA) Inclisiran提供了一个新的治疗选择.
- 患者可能对他类药物,ezetimibe和bempedoic acid等现有疗法有禁忌或反应不足.
研究的目的:
- 报告一种罕见的固定药物喷发病例,由inclisiran.
- 突出针对基于siRNA的新型疗法的潜在皮肤不良反应.
- 强调在接受新型降脂剂的患者皮肤病监测的重要性.
主要方法:
- 一个72岁的男性患有耐火性高胆固醇血症的病例报告.
- 在inclisiran治疗后出现皮肤不良反应的临床观察.
- 皮肤学评估包括皮肤活检以确认固定的药物喷发.
- 重新引入一种替代性降脂剂 (bempedoic acid) 来评估复发情况.
主要成果:
- 患者在第二次安克利西兰注射后,在腹部和腿部出现的红血性皮疹.
- 皮肤活检证实了固定的药物喷发.
- 症状通过局部治疗和抗组胺药物得到缓解.
- 佩多酸被重新引入,皮疹没有复发,这表明成功的替代性脂质管理.
结论:
- 针对PCSK9的siRNA疗法Inclisiran可以导致罕见的皮肤不良事件,如固定的药物喷发.
- 对于接受新型降脂药物治疗的患者,警性皮肤病监测至关重要.
- 替代疗法,如bempedoic酸,可以有效控制脂质在患者之前与治疗相关的不良事件.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
449
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
449
01:29Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
01:21Drugs for Treatment of Constipation-Predominant IBS
698
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
698
01:01Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K